On this page
BCS1L
BCS1 ubiquinol-cytochrome c reductase complex chaperone
The BCS1L gene provides instructions for a mitochondrial protein that is essential for the assembly of complex III, a key component in cellular energy production. The BCS1L gene plays a vital role in the function of mitochondria, the cellular powerhouses responsible for converting food into usable energy.
BCS1L is located on the long (q) arm of chromosome 2, at band 2q35. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 2 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The BCS1L gene encodes a protein integral to mitochondrial function and cellular energy metabolism. Mitochondria are organelles within cells responsible for generating adenosine triphosphate (ATP), the primary energy currency of the cell, through a process called oxidative phosphorylation.
Disruptions to the BCS1L protein's function can impair this crucial energy production pathway, leading to a spectrum of inherited disorders affecting multiple organ systems.
What the gene does
The BCS1L protein is critical for the proper assembly and function of mitochondrial complex III, also known as ubiquinol-cytochrome c reductase. This complex is a key component of the electron transport chain within mitochondria, where a series of protein complexes facilitate oxidative phosphorylation.
Specifically, BCS1L is involved in incorporating the Rieske iron-sulphur protein, a vital subunit, into complex III. Complex III uses oxygen and simple sugars to produce ATP. During this process, complex III also generates reactive oxygen species, which, while potentially harmful at high levels, are thought to be involved in normal cellular signalling, particularly in low-oxygen conditions. Some research also suggests a role for the BCS1L protein in iron metabolism, although the precise mechanism remains unclear.
Video: Genetics 101
Chromosome location
The BCS1L gene is located on chromosome 2 at position 2q35. This chromosomal location indicates its specific address within the human genome.
Protein structure
Domain architecture has not been experimentally characterised in detail for this protein.
Key variants
Variants in the BCS1L gene can alter the protein's structure and function, impacting its role in mitochondrial complex III assembly. These genetic changes can range from single nucleotide substitutions to larger deletions or insertions.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1026dup | p.Arg343fs | Pathogenic/Likely pathogenic | ★★☆☆ | BCS1L-related disorder |
c.180T>G | p.Tyr60Ter | Pathogenic/Likely pathogenic | ★★☆☆ | BCS1L-related disorder |
c.1A>T | p.Met1Leu | Pathogenic/Likely pathogenic | ★★☆☆ | GRACILE syndrome |
c.340C>T | p.Arg114Trp | Pathogenic/Likely pathogenic | ★★☆☆ | BCS1L-related disorder |
c.478C>T | p.Gln160Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Pili torti-deafness syndrome |
c.493A>T | p.Lys165Ter | Pathogenic/Likely pathogenic | ★★☆☆ | GRACILE syndrome |
c.588_591dup | p.Ala198fs | Pathogenic/Likely pathogenic | ★★☆☆ | GRACILE syndrome |
c.671_675del | p.Arg224fs | Pathogenic/Likely pathogenic | ★★☆☆ | BCS1L-related disorder |
c.703G>C | p.Gly235Arg | Pathogenic/Likely pathogenic | ★★☆☆ | Pili torti-deafness syndrome |
c.793C>T | p.Arg265Ter | Pathogenic/Likely pathogenic | ★★☆☆ | GRACILE syndrome |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the BCS1L gene are associated with several inherited conditions, primarily affecting mitochondrial function. These include GRACILE syndrome, a severe disorder with systemic effects, and Björnstad syndrome, characterised by hair abnormalities and hearing loss. BCS1L variants can also lead to mitochondrial complex III deficiency, which often presents with liver, kidney, and brain involvement, as well as Leigh syndrome.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
Inheritance pattern
Conditions caused by pathogenic BCS1L variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
The BCS1L gene is recognised within the UK's NHS Genomic Medicine Service, appearing on several green-rated PanelApp panels. These include panels for Cholestasis, DDG2P, Dystonia, chorea or related movement disorder (childhood onset), Early onset or syndromic epilepsy, Foetal anomalies, Inherited white matter disorders, Intellectual disability, Likely inborn error of metabolism, Mitochondrial disorders, Mitochondrial disorder with complex III deficiency, Mitochondrial liver disease, Monogenic hearing loss, Possible mitochondrial disorder (nuclear genes), Structural basal ganglia disorders, Undiagnosed metabolic disorders, and White matter disorders and cerebral calcification (childhood onset).
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the main role of the BCS1L gene?
The BCS1L gene provides instructions for a protein that is crucial for the assembly and function of mitochondrial complex III, a key part of the cellular machinery that produces energy (ATP).
What happens if the BCS1L gene does not function correctly?
If the BCS1L gene does not function correctly, it can impair mitochondrial energy production. This can lead to various inherited metabolic conditions affecting multiple organ systems, such as GRACILE syndrome, Björnstad syndrome, and mitochondrial complex III deficiency.
How is the BCS1L gene related to mitochondria?
The BCS1L gene encodes a protein that works within the mitochondria, which are often called the 'powerhouses' of the cell. This protein is essential for building a specific part of the mitochondrial electron transport chain, called complex III, which is vital for converting food into usable energy.
References
- Bleier L, Dröse S. Superoxide generation by complex III: from mechanistic rationales to functional consequences. Biochimica et biophysica acta. 2013. PMID: 23269318
- Morán M, Marín-Buera L, Gil-Borlado MC. Cellular pathophysiological consequences of BCS1L mutations in mitochondrial complex III enzyme deficiency. Human mutation. 2010. PMID: 20518024
- Gil-Borlado MC, González-Hoyuela M, Blázquez A. Pathogenic mutations in the 5' untranslated region of BCS1L mRNA in mitochondrial complex III deficiency. Mitochondrion. 2009. PMID: 19389488
- Hinson JT, Fantin VR, Schönberger J. Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome. The New England journal of medicine. 2007. PMID: 17314340
- Fernandez-Vizarra E, Bugiani M, Goffrini P. Impaired complex III assembly associated with BCS1L gene mutations in isolated mitochondrial encephalopathy. Human molecular genetics. 2007. PMID: 17403714
- Visapää I, Fellman V, Vesa J. GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. American journal of human genetics. 2002. PMID: 12215968
- de Lonlay P, Valnot I, Barrientos A. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nature genetics. 2001. PMID: 11528392